Tag: presentations

THE WOODLANDS, Texas, July 06, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 496 homes in June 2026, including 29 currently or previously leased single-family rental homes. This represents an 8.5% increase compared to 457 homes closed in June 2025. Additionally, the Company closed 1,440 homes during the second quarter of 2026, including 75 currently or previously leased single-family rental homes. This represents an 8.8% increase compared to 1,323 homes closed in the second quarter of 2025.

Apex Auto Solutions Inc. Announces Transformation Into DRIVE POINT EXCHANGE, Fixing Problems Created at Dealerships and Partnering With Major Manufacturers, NAAC, and Insurify.com

LIKMEZ® (ATI-1501) commercial momentum building in U.S. market

US$40 million NIAID award supporting VXV-01 advancement through Phase 1

BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host an investor event to discuss updates for the Company’s nomlabofusp clinical development program including a regulatory update and data from the ongoing long-term open label study for the treatment of Friedreich’s ataxia on Monday, June 29, 2026 at 7:45 am ET.

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the Company’s lead cell therapy candidate for Duchenne Muscular Dystrophy (DMD). The data will be presented at the Parent Project Muscular Dystrophy (PPMD) 2026 Annual Conference, taking place June 25-27, 2026, in Orlando, Florida, alongside previously reported results from the Company’s HOPE-3 Phase 3 trial.

JACKSONVILLE, Fla., June 25, 2026 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its second quarter 2026 earnings results on Wednesday, July 29, 2026, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Thursday, July 30, 2026, at 11:00 a.m. ET.